ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,656.61
0.39%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Applied Therapeutics Inc (APLT)

  7. Applied Therapeutics Inc (APLT) Noticias

APLT Applied Therapeutics Inc

4.28
0.05 (1.18%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Applied Therapeutics Inc APLT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.05 1.18% 4.28 23:00:04
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.33 4.24 4.45 4.28 4.23
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
15/4/202406:00GLOBEApplied Therapeutics Appoints Dale Hooks as Chief Commercial..
04/4/202406:00GLOBEApplied Therapeutics to Present Results from Phase 3..
28/3/202415:30GLOBEApplied Therapeutics Provides FDA Update on PDUFA Target..
11/3/202407:17EDGAR2Form 8-K - Current report
06/3/202406:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202406:12EDGAR2Form 8-K - Current report
06/3/202406:00GLOBEApplied Therapeutics Reports Fourth Quarter and Year-end..
05/3/202416:42EDGAR2Form SC 13D/A - General statement of acquisition of..
29/2/202415:18EDGAR2Form 8-K - Current report
28/2/202407:05GLOBEApplied Therapeutics Announces $100 Million Private..
28/2/202407:00GLOBEApplied Therapeutics Announces FDA Acceptance and Priority..
22/2/202413:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202406:07EDGAR2Form 8-K - Current report
15/2/202406:00GLOBEApplied Therapeutics Announces Positive Results from..
14/2/202420:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202416:02EDGAR2Form 8-K - Current report
04/1/202415:05GLOBEApplied Therapeutics Announces Topline Results from the..
03/1/202410:20DJNApplied Therapeutics Shares Hit 52-Week High on Govorestat..
03/1/202408:15EDGAR2Form 8-K - Current report
03/1/202406:00GLOBEApplied Therapeutics Announces MAA Validation and NDA..
29/12/202315:23EDGAR2Form 8-K - Current report
22/12/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202318:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202315:11EDGAR2Form 8-K - Current report
13/11/202316:10EDGAR2Form SC 13D/A - General statement of acquisition of..
09/11/202306:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:36EDGAR2Form 8-K - Current report
09/11/202306:30GLOBEApplied Therapeutics Reports Third Quarter 2023 Financial..
03/11/202315:37EDGAR2Form 144 - Report of proposed sale of securities
02/11/202315:33EDGAR2Form 144 - Report of proposed sale of securities
02/11/202306:00GLOBEApplied Therapeutics to Present at the UBS Biopharma..
01/11/202315:42EDGAR2Form 144 - Report of proposed sale of securities
01/11/202306:00GLOBEApplied Therapeutics to Host Diabetic Cardiomyopathy Expert..
31/10/202315:42EDGAR2Form 144 - Report of proposed sale of securities
13/10/202315:42EDGAR2Form 8-K - Current report
29/9/202319:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202319:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202319:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202306:00GLOBEApplied Therapeutics to Present Baseline Data from Phase 3..
06/9/202310:08DJNApplied Therapeutics Shares Rise 11% After Pre-NDA Meeting..
06/9/202306:12EDGAR2Form 8-K - Current report
06/9/202306:00GLOBEApplied Therapeutics Announces Successful Pre-NDA Meeting..
11/8/202315:50EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
APLT
Applied Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados